Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Tedor Pharma, Inc.
FDA Inspection
•Tedor Pharma, Inc.•April 20, 2017

Tedor Pharma, Inc. – FDA Inspection, Apr 20, 2017

Record Details

This FDA Inspection record concerns Tedor Pharma, Inc., with an inspection on April 20, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Tedor Pharma, Inc.
Inspection Date
April 20, 2017
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Jonathan G. Matrisciano (FDA Associated Person)
View Company Profile

ID · 6d50ae4a-31d4-4a0a-a156-4831edc01911

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1010372
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

4
  1. 21 CFR 211.192Extent of discrepancy, failure investigations
  2. 21 CFR 211.113(a)Procedures for non-sterile drug products
  3. 21 CFR 211.186(b)(9)Manufacturing Instructions and Specifications
  4. 21 CFR 211.180(e)(2)Items to cover on annual reviews

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Tedor Pharma, Inc.

4
DateClassificationOfficeProject area
June 5, 2025VAINew England District OfficeDrug Quality Assurance
January 31, 2019VAICenter for Drug Evaluation and ResearchNew Drug Evaluation
October 29, 2013VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 9, 2011VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for Tedor Pharma, Inc.
  • FDA Inspection 1271887 - 2025-06-05
  • FDA Inspection 1077786 - 2019-01-31
  • FDA Inspection 853221 - 2013-10-29
  • FDA Inspection 743987 - 2011-09-09

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Tedor Pharma, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.